The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity

Research output: Contribution to journalReviewResearchpeer-review

Standard

The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men : The mechanisms and roles of increased bone marrow adiposity. / Ali, Dalia; Tencerova, Michaela; Figeac, Florence; Kassem, Moustapha; Jafari, Abbas.

In: Frontiers in Endocrinology, Vol. 13, 981487, 2022.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Ali, D, Tencerova, M, Figeac, F, Kassem, M & Jafari, A 2022, 'The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity', Frontiers in Endocrinology, vol. 13, 981487. https://doi.org/10.3389/fendo.2022.981487

APA

Ali, D., Tencerova, M., Figeac, F., Kassem, M., & Jafari, A. (2022). The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity. Frontiers in Endocrinology, 13, [981487]. https://doi.org/10.3389/fendo.2022.981487

Vancouver

Ali D, Tencerova M, Figeac F, Kassem M, Jafari A. The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity. Frontiers in Endocrinology. 2022;13. 981487. https://doi.org/10.3389/fendo.2022.981487

Author

Ali, Dalia ; Tencerova, Michaela ; Figeac, Florence ; Kassem, Moustapha ; Jafari, Abbas. / The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men : The mechanisms and roles of increased bone marrow adiposity. In: Frontiers in Endocrinology. 2022 ; Vol. 13.

Bibtex

@article{b7acb924dd564d24906ebd199ee23035,
title = "The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity",
abstract = "Osteoporosis is defined as a systemic skeletal disease characterized by decreased bone mass and micro-architectural deterioration leading to increased fracture risk. Osteoporosis incidence increases with age in both post-menopausal women and aging men. Among other important contributing factors to bone fragility observed in osteoporosis, that also affect the elderly population, are metabolic disturbances observed in obesity and Type 2 Diabetes (T2D). These metabolic complications are associated with impaired bone homeostasis and a higher fracture risk. Expansion of the Bone Marrow Adipose Tissue (BMAT), at the expense of decreased bone formation, is thought to be one of the key pathogenic mechanisms underlying osteoporosis and bone fragility in obesity and T2D. Our review provides a summary of mechanisms behind increased Bone Marrow Adiposity (BMA) during aging and highlights the pre-clinical and clinical studies connecting obesity and T2D, to BMA and bone fragility in aging osteoporotic women and men.",
keywords = "aging, bone fragility, bone marrow adiposity, obesity, osteoporosis, type 2 diabetes (T2D)",
author = "Dalia Ali and Michaela Tencerova and Florence Figeac and Moustapha Kassem and Abbas Jafari",
note = "Publisher Copyright: Copyright {\textcopyright} 2022 Ali, Tencerova, Figeac, Kassem and Jafari.",
year = "2022",
doi = "10.3389/fendo.2022.981487",
language = "English",
volume = "13",
journal = "Frontiers in Endocrinology",
issn = "1664-2392",
publisher = "Frontiers Media S.A.",

}

RIS

TY - JOUR

T1 - The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men

T2 - The mechanisms and roles of increased bone marrow adiposity

AU - Ali, Dalia

AU - Tencerova, Michaela

AU - Figeac, Florence

AU - Kassem, Moustapha

AU - Jafari, Abbas

N1 - Publisher Copyright: Copyright © 2022 Ali, Tencerova, Figeac, Kassem and Jafari.

PY - 2022

Y1 - 2022

N2 - Osteoporosis is defined as a systemic skeletal disease characterized by decreased bone mass and micro-architectural deterioration leading to increased fracture risk. Osteoporosis incidence increases with age in both post-menopausal women and aging men. Among other important contributing factors to bone fragility observed in osteoporosis, that also affect the elderly population, are metabolic disturbances observed in obesity and Type 2 Diabetes (T2D). These metabolic complications are associated with impaired bone homeostasis and a higher fracture risk. Expansion of the Bone Marrow Adipose Tissue (BMAT), at the expense of decreased bone formation, is thought to be one of the key pathogenic mechanisms underlying osteoporosis and bone fragility in obesity and T2D. Our review provides a summary of mechanisms behind increased Bone Marrow Adiposity (BMA) during aging and highlights the pre-clinical and clinical studies connecting obesity and T2D, to BMA and bone fragility in aging osteoporotic women and men.

AB - Osteoporosis is defined as a systemic skeletal disease characterized by decreased bone mass and micro-architectural deterioration leading to increased fracture risk. Osteoporosis incidence increases with age in both post-menopausal women and aging men. Among other important contributing factors to bone fragility observed in osteoporosis, that also affect the elderly population, are metabolic disturbances observed in obesity and Type 2 Diabetes (T2D). These metabolic complications are associated with impaired bone homeostasis and a higher fracture risk. Expansion of the Bone Marrow Adipose Tissue (BMAT), at the expense of decreased bone formation, is thought to be one of the key pathogenic mechanisms underlying osteoporosis and bone fragility in obesity and T2D. Our review provides a summary of mechanisms behind increased Bone Marrow Adiposity (BMA) during aging and highlights the pre-clinical and clinical studies connecting obesity and T2D, to BMA and bone fragility in aging osteoporotic women and men.

KW - aging

KW - bone fragility

KW - bone marrow adiposity

KW - obesity

KW - osteoporosis

KW - type 2 diabetes (T2D)

U2 - 10.3389/fendo.2022.981487

DO - 10.3389/fendo.2022.981487

M3 - Review

C2 - 36187112

AN - SCOPUS:85139015283

VL - 13

JO - Frontiers in Endocrinology

JF - Frontiers in Endocrinology

SN - 1664-2392

M1 - 981487

ER -

ID: 323839727